Table 2 Summary statistics for TMA markers on 82 patients
From: Protein expression based multimarker analysis of breast cancer samples
TMA Marker | 25th | Median | 75th | # (% NA) |
|---|---|---|---|---|
14-3-3 σ | 5 | 33 | 63 | 79 (4%) |
Annexin A1 | 0 | 0 | 6 | 82 (0%) |
Beta-catenin | 73 | 90 | 98 | 76 (7%) |
BS106 | 0 | 3 | 30 | 79 (4%) |
BU101 | 67 | 95 | 100 | 78 (5%) |
MED28 expressed in the cytoplasm (cyt) | 42 | 67 | 90 | 77 (6%) |
MED28 expressed in the nucleus (nuc) | 40 | 60 | 80 | 77 (6%) |
Estrogen Receptor α (ER α) | 2 | 18 | 50 | 78 (5%) |
GATA3 | 27 | 79 | 100 | 82 (0%) |
HER-2/neu | 15 | 37 | 77 | 77 (6%) |
Histone H3, acetylated on K4 (H3K4) | 80 | 87 | 95 | 74 (10%) |
Histone H3, acetylated on K18 (H3K18) | 84 | 90 | 97 | 74 (10%) |
Mammaglobin | 17 | 57 | 83 | 80 (2%) |
Na-K ATPase-α | 33 | 58 | 80 | 75 (9%) |
Na-K ATPase-β1 | 40 | 70 | 92 | 74 (10%) |
p53 | 0 | 4 | 23 | 80 (2%) |
Progesterone Receptor (PR) | 0 | 15 | 57 | 78 (5%) |
Prolactin inducible protein | 0 | 0 | 1 | 79 (4%) |
RIN-1 | 85 | 93 | 100 | 79 (4%) |
Smad2 | 83 | 97 | 100 | 79 (4%) |
Smad4 cyt | 63 | 90 | 97 | 78 (5%) |
Smad4 nuc | 50 | 79 | 88 | 78 (5%) |
TGF-β receptor II cyt | 3 | 10 | 35 | 78 (5%) |
TGF-β receptor II nuc | 32 | 53 | 73 | 78 (5%) |
S100A7 | 0 | 0 | 0 | 74 (10%) |
Ying Yang 1 (YY1) | 90 | 95 | 100 | 76 (7%) |